WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 September 2020 Issue has been Published, Kindly check it on http://www.wjahr.com/home/current_issues

  • WJAHR SEPTEMBER ISSUE PUBLISHED

    SEPTEMBER 2020 Issue has been successfully launched on 1 September 2020.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

CHARACTERISTICS OF INPATIENTS’ FATALITY DUE TO COVID-19 PANDEMIC: EXPERIENCE FROM MUGDA MEDICAL COLLEGE AND HOSPITAL, DHAKA, BANGLADESH

Dr. Irin Hossain*, Prof. Dr. Manzurul Haque Khan, Dr. Sk Akhtar Ahmad, Dr. M. M. Aktaruzzaman, Dr. Shah Golam Nabi Tuhin, Dr. Md. Shafiur Rahman, Dr. Ashekur Rahman Mullick*, Dr. Md. Shahin, Dr. Adnan Yusuf Choudhury, Dr. Md Abdul Hamid, Dr. Md

ABSTRACT

COVID-19 was firstly reported in Wuhan, Hubei Province, China at the end of 2019. As of July 26, 2020, COVID-19 has cause over 16.25 million infections and over 0.65 million deaths around the world. In Bangladesh, more than 0.22 million patients infected with COVID-19 and among them near about three thousand have been died. We aimed to explore risk factors of in-hospital death for patients and describe the clinical course of symptoms, associate baseline risk factors, treatment strategy. We conducted a retro-prospective study of 98 deceased patients who were admitted into COVID-19 dedicated Mugda Medical College and Hospital, Dhaka, Bangladesh for treatment purpose from May 1 to June 30, 2020. Data were obtained from patient charts and the hospitals’ admission records using a structured questionnaire. The overall age of 98 death patients was estimated 57.65 ± 17.597 years with the median of 60 years old. Among the fatal cases, 76 (77.6%) were males. Based on the history of underlying diseases in the dead’s, it was found that most of them had diabetes (55, 56.1%) and hypertension (55, 56.1%). The main clinical symptoms were shortness of breath (90, 91.8%) and fever (72, 73.5%). Among the deceased patient about 49.0% patient need ICU/HDU support for treatment purpose. Patients with coexisting conditions and older age are at risk for severe disease followed by death. Overall, informing people in the community especially the high-risk groups providing the medical supplies, increasing laboratory tests capacity, performing social distance, banning public gathering, and announcing quarantine were panic management strategies which could moderate the death cases.

[Full Text Article]